Posts for Ticker ‘NVAX’

Top Day Trader Alerts (BCRX, DELL, DRYS, NVAX, WCRX)

These are this morning’s top day trader alerts and active trader alerts early this Friday morning.  We have links through to each stock at VSInvestor.com with more data and analysis on each:

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) down almost 6% on its secondary offering.

Dell Inc. (NASDAQ: DELL) is down 8% on earnings, but we came up with the technical levels to watch in moving averages and prior pivot points.

DryShips Inc. (NASDAQ: DRYS) is down almost 4% after it increased the size of its convertible note offering.

Novavax, Inc. (NASDAQ: NVAX) is trading down 10% on a secondary offering on deck.

Warner Chilcott plc (NASDAQ: WCRX) is down only 2% after insiders and private equity holders are selling shares in a secondary offering.

You can join our open email distribution list to hear more news on key analyst calls, top day trader alerts, mergers and acquisitions, Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG
NOVEMBER 20, 2009

Posted on: November 20, 2009 – 8:44 am in Pre-Market Activity, Trading Alert, , , , ,

Top Analyst Upgrades, Downgrades, Initiations (BRK-A, CMCSA, MDT, TAP, NVAX, LNUX, THQI, YMI)

These are this mornings top analyst upgrades, downgrades, and initiations seen early this Thursday from Wall Street research calls:

Berkshire Hathaway Inc. (BRK-A) was put on CreditWach (negative) on Wednesday afternoon, which would take the AAA away to match where Moody’s already is.
Comcast (CMCSA) Cut to Hold at Collins Stewart.
Medtronic (MDT) Raised to Outperform at Credit Suisse.
Molson Coors (TAP) Cut to Neutral at Goldman Sachs.
NovaVax (NVAX) Started as Buy at Merriman Curhan.
SourceForge (LNUX) Cut to Neutral at Merriman.
THQ Inc. (THQI) Cut to Hold at Deutsche Bank.
YM BioSciences (YMI) Started as Buy at Merriman Curhan.

You can join our open email distribution list to get updates on top analyst upgrades and downgrades, top day trader alerts, IPO’s, secondary offerings, Warren Buffett and other guru activity, M&A and more.

JON C. OGG

Posted on: November 5, 2009 – 8:23 am in Analyst Calls, , , , , , , ,

Top Day Trader Alerts (AAPL, BPAX, CAT, FNM, FRE, MGM, NVAX)

These are this morning’s top day trader alerts.  We have more detailed price and volume data along with added color over with links through to each stock at VSInvestor.com:

Apple Inc. (NASDAQ: AAPL) is bumping against all-time highs after blowing out earnings.

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) is one of this morning’s top gainers on safety reviews allowing the study to proceed.

Caterpillar Inc. (NYSE: CAT) is up at 52-week highs after blowing out earnings.

Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE) are continuing yesterday’s losses, with Freddie being slapped harder than the Fannie step-sister.

MGM MIRAGE (NYSE: MGM) is up close to 10% on word that Kerkorian’s Tracinda is interested in exploring deals after the December City Center open.

Novavax, Inc. (NASDAQ: NVAX) is up 6% on a test of virus-like particle H1N1 influenza vaccine in Mexico with Avimex Laboratories and GE Healthcare.

You can join our open email distribution list to get updates on top analyst upgrades and downgrades, top day trader alerts, IPO’s, secondary offerings, Warren Buffett and other guru activity, M&A and more.

JON C. OGG

Posted on: October 20, 2009 – 8:58 am in After-Hours Activity, Pre-Market Activity, Trading Alert, , , , , , ,

Top Day Trader Alert Stocks (CIT, C, GS, JNJ, NVAX, VNDA, VASC)

These are this morning’s top day trader alert stocks.  We have more detailed price and volume analysis on each stock link over at VSInvestor.com:

CIT Group Inc. (NYSE: CIT) is getting crushed and is back under $1.00 on its news this morning.

Goldman Sachs Group Inc. (NYSE: GS) is down almost 2% on the Meredith Whitney downgrade.

Citigroup, Inc. (NYSE: C) is up marginally despite an analyst “BUY” recommendation.

Johnson & Johnson (NYSE: JNJ) is down 2.5% at $60.95 despite beating earnings because revenues were light and ‘raised guidance’ looks effectively in-line.

Novavax, Inc. (NASDAQ: NVAX) is rising over 7% on a small NIH grant.

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is one of this morning’s top gainers on a a Novartis pact.

Vascular Solutions, Inc. (NASDAQ: VASC) is another top percentage gainer on FDA marketing approval for its next-generation Guardian II Hemostasis valve.

You can join our open email distribution list to get updates each morning on analyst upgrades and downgrades, top day trader alerts, IPO’s and secondary offerings, Warren Buffett and other guru activity, M&A and more.

JON C. OGG
OCTOBER 13, 2009

Posted on: October 13, 2009 – 9:15 am in After-Hours Activity, Pre-Market Activity, Trading Alert, , , , , , ,

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

These are the top ten analyst research initiations, upgrades, and downgrades we have seen from top Wall Street firms early this Wednesday morning:

Biogen-Idec (BIIB) Started as Underperform at BofA/Merrill Lynch.
Forest Labs (FRX) Cut to Hold at Needham.
Genzyme (GENZ) Started as Buy at BofA/Merrill Lynch.
Gilead (GILD) Started as Buy at BofA/Merrill Lynch.
Hologic (HOLX) Cut to Hold at Canaccord.
Las Vegas Sands (LVS) Raised to Buy at Argus.
Mosaic (MOS) Started as Sector Perform at CIBC.
Novavax (NVAX) Cut to Market Perform at Rodman & Renshaw.
Transocean (RIG) Started as Outperform at BMO Capital.
Textron (TXT) Raised to Conviction Buy List at Goldman Sachs.

JON C. OGG

Posted on: September 2, 2009 – 8:21 am in Analyst Calls, , , , , , , , , ,

Top Day Trader Alerts (AIG, CMED, FNM, FRE, NVAX, RMBS, SQNM)

These are this Tuesday’s top day trader and active trader alert stocks.  We have links through to each with more detailed price/volume analysis over at VSinvestor.com:

American International Group, Inc. (NYSE: AIG) is getting hit again, but this time on a brokerage firm downgrade.

China Medical Technologies, Inc. (NASDAQ: CMED) is down on fairly active volume after it announced that revenues rose 29% but the net loss or earnings were down over 90%.

Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE) are seeing a second morning of selling with most other speculative financial stocks.

Novavax, Inc. (NASDAQ: NVAX) is hitting 52-week highs on positive flu study data.

Rambus Inc. (NASDAQ: RMBS) continues the selling this morning after after-hours selling on unconfirmed data.

SEQUENOM Inc. (NASDAQ: SQNM) is trading lower and giving back much of Monday’s gain since no news has hit regarding its Down’s test….

If you wish to be notified by email when the top day trader alerts hit, along with news of IPO’s, key offerings, guru investor data on Buffett and others, mergers, and more, you can join our open email distribution list which goes out several times per week.

JON C. OGG

Posted on: September 1, 2009 – 8:53 am in Pre-Market Activity, Trading Alert, , , , , , ,

Top Day Trader Alerts (ARAY, COCO, GME, HGSI, NVAX, BCRX, SIRI)

These are this Tuesday’s top day trader and active trader alerts with more detailed price and volume data and analysis provided by links to each story at VSInvestor.com:

Accuray Incorporated (NASDAQ: ARAY) is down but not as active on the heels of active trading last night.  We saw a drop of 10% still being in the stock….

Corinthian Colleges, Inc. (NASDAQ: COCO) did beat earnings and raise guidance, sending shares up 12% and still under the 52-week highs.  Watch APOL and CECO on the news….

GameStop Corp. (NYSE: GME) is indicated marginally lower after losing its CFO.

Human Genome Sciences, Inc. (NASDAQ: HGSI) was up the most of the active biotechs up over 7% on yesterday’s deal hopes and today’s swine flu hopes.

Novavax Inc. (NASDAQ: NVAX) and BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) are both actively traded and higher this morning because of the swine flu boost.

SIRIUS XM Radio Inc. (NASDAQ: SIRI) is looking a little tired, but this would be a 6th day gain if it can stay strong again.

-The 24/7 Wall Street Team

Posted on: August 25, 2009 – 9:13 am in Pre-Market Activity, Trading Alert, , , , , , ,

Top Day Trader Alerts (HD, LOW, CIT, GERN, TSL, NVAX, HURN, RIMM)

These are this Tuesday’s top day trader and active stock alerts.  We have more detailed data on volume and price analysis with links through to VSInvestor.com on each stock:

The Home Depot, Inc. (NYSE: HD) managed to do better than rival Lowe’s Companies (NYSE: LOW) and shares were up 4%.

CIT Group, Inc. (NYSE: CIT) has pulled an about-face and is now higher after its big loss.

Geron Corporation (NASDAQ: GERN) is down sharply on its IND application delay.

Trina Solar Ltd. (NYSE: TSL) is trading up over 3% after the Chinese solar player managed to beat earnings estimates.

Novavax Inc. (NASDAQ: NVAX) is soaring 10% on swine flu vaccine news.

Huron Consulting Group Inc. (NASDAQ: HURN) is surging over 25% on a partial redemption of its accounting woes.

Research in Motion Ltd. (NASDAQ: RIMM) is up 2.5% but may be more active after an analyst is calling for a double.

JON C. OGG
AUGUST 18, 2009

Posted on: August 18, 2009 – 9:06 am in Pre-Market Activity, Trading Alert, , , , , , , ,

Top Day Trader Alerts (ACAS, GRMN, NVAX, ONT, PG, USU, WFMI)

These are this morning’s top day trader and active trader alerts.  We have links through to VSInvestor.com for more detailed price and volume analysis on each stock:

American Capital Ltd. (NASDAQ: ACAS) is down a sharp 20% on a wide loss and issue on its covenants.

Garmin Ltd. (NASDAQ: GRMN) is up huge in pre-market trading after earnings were less-bad.

Novavax, Inc. (Nasdaq: NVAX) is soaring as one of NASDAQ’s most active issues.  The company has manufactured a virus-like particle vaccine candidate against the H1N1 pandemic influenza virus.

On2 Technologies (NYSE AMEX: ONT) is up almost 55% at $0.59 after a Google buyout deal.

Procter & Gamble Co. (NYSE: PG) is down almost 4% on weak earnings metrics and choppy guidance.

USEC Inc. (NYSE: USU) is up over 12% after a DOE delay on the loan guarantee application.

Whole Foods Market, Inc. (NASDAQ: WFMI) is hitting 52-week highs on strong earnings and a slight return to growth.

The 24/7 Wall St. Team

Posted on: August 5, 2009 – 8:56 am in Pre-Market Activity, Trading Alert, , , , , , ,

Europe Steps Up Timetable On Swine Flu Vaccines (VICL, NVAX, BCRX)

earthShares of vaccine makers including Vical Inc. ((Nasdaq: VICL), Novavax Inc. (Nasdaq: NVAX) and BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) all are up strongly Monday after Europe’s version of the FDA decided to fast-track swine flu vaccine testing, making producers of the yet-to-be-approved inoculations potentially closer to bringing their products to market. Read More »

Posted on: July 27, 2009 – 10:53 am in Biotech, Drug companies, Pharmaceuticals, , ,

Top Day Trader Alerts (AA, CENX, NTAP, DDUP, EMC, RIGL, NVAX, HGSI, CPKI, SCSC)

Money Stack ImageThese are some of the this morning’s top day trader alert stocks to watch based on pre-market and after-hours volume activity.  These have links through to more detailed trading and volume analysis covered at the Volume Spike site VSInvestor.com:

  • Alcoa Inc. (NYSE: AA) shares are ones to watch for a volume spike higher after the company beat Q2 expectations by 12 cents a share and saw signs of auto market stability. Also watch rival Century Aluminum (Nasdaq: CENX) for possible upside.
  • NetApp Inc. (Nasdaq: NTAP) shares are pointing higher as the company saved some dough, and actually made a little, by losing its bid for data storage company Data Domain Inc. (Nasdaq: DDUP) to EMC Corp. (NYSE: EMC).
  • Rigel Pharmaceuticals Inc. (Nasdaq: RIGL) shares are up very strongly on clinical trial data that raised expectations for a partnership.
  • Novavax Inc. (Nasdaq: NVAX) shares are up more than 10 percent with nearly 100,000 shares traded in the pre-market after the company announced a joint venture in India with Cadila Pharmaceuticals, called CPL Biologicals.
  • Human Genome Sciences Inc. (Nasdaq: HGSI) shares are rising on strong volume on a New England Journal of Medicine publication regarding its Raxibacumab as a treatment for anthrax.
  • California Pizza Kitchen Inc. (Nasdaq: CPKI) shares will be ones to watch for a potential volume spike higher after the company guided Q2 profit higher.
  • ScanSource Inc. (Nasdaq: SCSC) shares could be active in early Thursday trading after the company guided higher for its fiscal Q4, ended in June.

-The 24/7 Wall St. Team

Posted on: July 9, 2009 – 7:49 am in After-Hours Activity, Pre-Market Activity, Trading Alert, , , , , , , , , ,

The Unusual Suspects (X, BRK-A, BNI, NFLD, INTC, WIND, AAPL, PALM, NVAX)

newspaperThere were several unusual occurrences at the end of the week and some we saw over the weekend screenings for items missed during the week.  These will also be among some of the top issues for Monday and Tuesday of this week:

Read More »

Posted on: June 7, 2009 – 6:31 am in Trading Alert, , , , , , , , ,

Speculative Swine Flu Stocks Make Last Stand (NVAX, GNBT, BCRX, PURE, VICL, VIVO, AVII)

It looks like everyone has figured out that swine flu was more of a media pandemic rather than a disease or viral pandemic.  Had this been November as flu season was starting, that might have been a bigger deal.  We have seen substantial pullbacks after the massive gains seen in the speculative swine flu stocks.  Novavax, Inc. (NASDAQ: NVAX), Generex Biotechnology Corp. (NASDAQ: GNBT), BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Pure Bioscience (NASDAQ: PURE), Vical Inc (NASDAQ: VICL), Meridian Bioscience Inc. (NASDAQ: VIVO), and AVI BioPharma Inc. (NASDAQ: AVII) have all begun their overbought roll-over.
Read More »

Posted on: May 5, 2009 – 3:12 pm in Biotech, Trading Alert, , , , , , ,

Speculative Swine Flu Stocks Giving It Back (NVAX, GNBT, BCRX, PURE, VICL, VIVO, AVII)

burning-money-pic32This week there have been many crazy stock gains among the speculative biotech sector, and these were tied directly to the ’speculative stocks’ that could have any ties in reality, fiction, and even imagination to a cure or hope in the fight against Swine Flu or any other sort of flu for that matter.

As you will see below, Novavax, Inc. (NASDAQ: NVAX), Generex Biotechnology Corp. (NASDAQ: GNBT), BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Pure Bioscience (NASDAQ: PURE), Vical Inc (NASDAQ: VICL), Meridian Bioscience Inc. (NASDAQ: VIVO), and AVI BioPharma Inc. (NASDAQ: AVII) have all begun their overbought roll-over.
Read More »

Posted on: April 29, 2009 – 10:23 am in Biotech, Trading Alert, , , , , , ,

Flu Stock Index Continues Move Up (BRCX)(PURE)(NVAX)

water-lilies13The Tickerspy index of swine flu and bird flu stocks is up 21% as the market nears its close.

The index is being pushed higher by share in Biocryst Pharma (BRCX), which is up 70% on the day, Novavax (NVAX), which is up 68%, and Pure Bioscience (PURE), which is higher by 50%.

If the WHO and CDC begin to show less concern about the current virus, most of the stock will lose their gains.

Douglas A. McIntyre

Posted on: April 27, 2009 – 2:30 pm in Biotech, , ,

Swine Flu Lessons from SARS, Mad Cow & Bird Flu of Past (GILD, BCRX, NVAX, GNBT, VICL, AVII, CRXL, RHHBY, GSK, SFD, EWW, MXF)

burning-money-pic27Monday is looking like a SWINE FLU speculative flu stock stock bonanza, and we want to caution about some of the lessons of scares in the past of SARS, bird flu, Mad Cow, and even hoof & mouth as similar references.  The two approved drug treatments, not vaccines, which are being released are Tamiflu made by Roche (OTC: RHHBY) and Relenza made by GlaxoSmithkline (NYSE: GSK).  Gilead Sciences, Inc. (GILD) gets royalties from Roche for Tamiflu, and its shares are indicated north of $48.00 after a $45.80 close on Friday.  There are also waves of tier-two and tier-three stocks which could move on this news, but be advised that we have seen these pops in the past from SARS and Bird Flu which were followed ultimately by lower share prices and many of the speculative players disappeared.

Of the tier-two stocks, you have BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) and Novavax, Inc. (NASDAQ: NVAX).  Of the tier-three stocks you have Generex Biotechnology Corp. (NASDAQ: GNBT), Vical Inc. (NASDAQ: VICL), AVI Biopharma, Inc. (NASDAQ: AVII), and Crucell NV (NASDAQ: CRXL).  More descriptive data has been provided for each move.   On another scale, Smithfield Foods Inc. (NYSE: SFD), the iShares MSCI Mexico Investable Market Index (NYSE: EWW), and The Mexico Fund, Inc. (NYSE: MXF) have exposure here as well.
Read More »

Posted on: April 27, 2009 – 6:40 am in Biotech, Drug companies, Food, Medical, Pharmaceuticals, Regulation, Research, Trading Alert, , , , , , , , ,

Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)

If you thought biotech news was getting quiet going into earnings season, think again.

Acadia Pharmaceuticals Inc. (ACAD) presents Phase II data on pimavanserin, a treatment  for Parkinson’s disease psychosis (PDP) at the 60th American Academy of Neurology Annual Meeting today. According the results from the study, pimavanserin is safe and effective at improving psychosis scores without hindering motor abilities. Shares are up $0.46 to $8.36 on a 52-week range of $7.63 to $17.33.

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) up almost 3% in mid-morning trading. They announced that the earnings call is schedule for March 21. Trading at $30.42 on a 52-week range of $23.75 to $53.25.

CV Therapeutics, Inc. (NASDAQ: CVTX) soaring today after they announced Tuesday that they will receive $185 milliion from TPG-Axon Capital for rights to the sales of Lexiscan, a drug for patients that are unable to exercise during heart tests and was granted FDA approval last Thursday. Shares are up over 15% to $8.63 on a 52-week range of $5.41 to $13.74.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced pre-clinical findings in combinations of bisphosphonates and rHuPH20 at the American Association for Cancer Reseacrch conference today. The study showed that a combination of these molecules could reduce local irritation from chemotherapy by allowing a subcutaneous route of administration. Shares are up over 10% to $5.99 on a 52-week range of $4.19 to $11.00.

Kosan Biosciences Inc. (NASDAQ: KOSN) is still steadily rising after Monday announcement that Phase II testing for Epothilone KOS-1584 initiated. The drug targets patients with non-small cell lung cancer. Shares are up over 11% to $2.00 today. Monday, shares opened at $1.50. The 52-week range is $1.28 to $6.53.

Medicure Inc. (AMEX: MCU) up by 40% with the announcement that Phase II results for MC-1 and lisinpril for patients with type-II diabetes and hypertension will be presented at Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Annual Conference today. The data from the study was previously released. Shares are up 40% to $0.09 on a 52-week range of $0.05 to $1.64.

Novavax, Inc. (NASDAQ: NVAX) reported positive results in preclinical studies of Trivalent, a seasonal influenza vaccine. Phase II testing is hoped to begin in the third-quarter this year. Shares are up over 5% to $2.51. The 52-week range is $2.24 to $4.38.

Pozen, Inc. (NASDAQ: POZN) skyrocketing today on news that migraine drug Treximet has received FDA approval. They partnered with GlaxoSmithKline (GSK) for development of the drug. It is a follow up for Glaxo’s similar drug, Imitrex, which is set to lose patent protection in 2009. Pozen up 34% to $14.19 on a 52-week range of $8.29 to $19.75. Glaxo is up marginally to $42.57.

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) moving higher than the rest today on no new developments. Shares are up $1.37 to $19.60 on a 52-week range of $13.55 to $28.74.

Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT) published a report by Scientific Advisory Board Co-Chairs that showed first in-vivo data demonstrating that SIRT1 enzymes suppress tumor development in colon cancer cells. Shares are up almost 5% to $12.56 on a 52-week range of $9.50 to $21.99.

Rachel Lopez
April 16, 2008

Posted on: April 16, 2008 – 11:18 am in Biotech, , , , , , , , , ,